ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

COVID-19 Early Treatment with Non-Steroidal AntiInflammatory Drugs Reduces Hospitalizations and Symptom Duration |Biomedgrid

Journal: American Journal of Biomedical Science & Research (Vol.16, No. 1)

Publication Date:

Authors : ; ; ; ; ;

Page : 99-101

Keywords : Ibuprofen; Aspirin; Indomethacin; Nimesulide; Ketoprofen;

Source : Downloadexternal Find it from : Google Scholarexternal


At the beginning of the SARS-CoV-2 pandemic we stated that, given the new virus and the little-known disease it caused, in the absence of Evidence-Based Medicine indications, patients should have been treated with drugs already available, useful to counteract the pathophysiology of the COVID-19 [1]. Recent literature has confirmed that this could be a successful approach, demonstrating that an early treatment with nonsteroidal anti-inflammatory drugs (NSAIDs), in patients with mild-to-moderate COVID-19, produces significant reduction of hospitalizations and disease duration [2-4]. The NSAIDs have indication in the COVID-19 not only for their antiinflammatory actions but also, some molecules, for their antiviral properties [2,3,5].

Last modified: 2024-02-16 21:48:27